Related Experiment Videos

Enkephalin-induced myoclonic twitches blocked by ergometrine and potentiated by haloperidol

Psychopharmacology
|November 1, 1979
PubMed

Insights

Enkephalin-induced myoclonic twitches in rats suggest activation of a specific dopaminergic system. This system is sensitive to ergometrine but not haloperidol, offering new insights into neurotransmitter interactions.

Area of Science:

  • Neuropharmacology
  • Neurophysiology

Background:

  • Opioid peptides, like enkephalins, play crucial roles in modulating neuronal activity.
  • Understanding the specific receptor systems involved in enkephalin's effects is essential for neuroscience research.

Purpose of the Study:

  • To investigate the neurochemical mechanisms underlying enkephalin-induced myoclonic twitches (MT) in rat submandibular muscles.
  • To explore the involvement of dopaminergic and serotonergic systems in these enkephalin-mediated effects.

Main Methods:

  • Electromyographic (EMG) recordings were used to measure MT in rats.
  • Pharmacological agents including naloxone, gamma-hydroxybutyrate, ergometrine, haloperidol, and methysergide were administered to assess their effects on DALA-induced MT.

Main Results:

  • Intraventricular administration of D-ala2-met-enkephalinamide (DALA) induced significant MT.
  • These twitches were blocked by naloxone, gamma-hydroxybutyrate, and ergometrine.
  • Haloperidol potentiated the MT, while methysergide had no significant effect.

Conclusions:

  • The findings suggest a specific enkephalin-induced activation of an inhibition-mediating dopaminergic system.
  • This dopaminergic system appears to be sensitive to ergometrine blockade but resistant to haloperidol blockade.

Related Concept Videos